Resistance Exercise for Type 1 Diabetes

(FLEX-T1D Trial)

Not yet recruiting at 2 trial locations
JE
CS
Overseen ByCorinne Suppere, MSc
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Institut de Recherches Cliniques de Montreal
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Improvements in diabetes care and technology have led to people with type 1 diabetes living longer. There are now more seniors than ever living with this complex health condition. With aging, type 1 diabetes affects both bone (more brittle), and muscle (loss of size and strength). This loss happens faster and to a greater extent in females than in males, and greatly increases the risk of frailty and falls. It may also occur more quickly in individuals who have higher blood glucose (sugar) levels.

Frailty is an important factor to address. In older females, even mild frailty decreases the ability to perform day-to-day tasks, and increases the risk of fractures, falls, hospitalization, and even death. Performing regular exercise helps to maintain the strength and quality of both muscles and bones with aging. The best type of exercise to help maintain the ability to perform activities of daily living (known as functional mobility) for this population is currently unknown. Resistance exercise (weightlifting) helps to prevent decreases in mobility in seniors without diabetes. However, in the context of type 1 diabetes, high blood sugar levels could negatively impact these potential strength benefits and low blood glucose could lead to falls. As such, any exercise program that causes swings in glucose levels may hinder rather than help.

The goal of this study is to evaluate the effect of weightlifting over a 6-month timeframe on functional mobility in postmenopausal females with type 1 diabetes, compared to a group that does not train. the investigators will also assess its effects on blood sugar variability and the risk of hypoglycemia. Like different medications, not all exercise is equal. Creating more knowledge about the benefits of specific types of exercise in this population will allow us to be more precise in our exercise recommendations for living longer and more independently with type 1 diabetes.

Who Is on the Research Team?

JE

Jane E Yardley, PhD

Principal Investigator

Institut de Recherches Cliniques de Montreal

Are You a Good Fit for This Trial?

This trial is for postmenopausal women who have type 1 diabetes. Participants should be older adults living with this condition and able to safely take part in an exercise program.

Inclusion Criteria

Physically inactive (less than 30 minutes of aerobic activity less than 3 times per week; no resistance exercise)
I am female.
Postmenopausal (no menstrual periods in the previous 12 months, or have had a hysterectomy and bilateral salpingo-oophorectomy with at least 1 year elapsed since surgery)
See 2 more

Exclusion Criteria

Physical activity restrictions due to unstable cardiac or pulmonary disease
Unable to communicate in English or French
My high blood pressure is not controlled and limits my physical activity.
See 9 more

What Are the Treatments Tested in This Trial?

Interventions

  • Resistance exercise

Trial Overview

The study tests whether a regular weightlifting (resistance exercise) program over six months can improve movement, strength, and blood sugar control compared to not exercising in postmenopausal women with type 1 diabetes.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Resistance exerciseExperimental Treatment1 Intervention
Group II: wait-list controlActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Institut de Recherches Cliniques de Montreal

Lead Sponsor

Trials
72
Recruited
10,300+

McMaster University

Collaborator

Trials
936
Recruited
2,630,000+

University of Alberta

Collaborator

Trials
957
Recruited
437,000+